Clinical Trial Update: Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of telmisartan and simvastatin for hypertension and hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Dyslipidemias | Phase 3 | Status: COMPLETED